12-Mar-2020 | Facts and Factors
Findings from Facts and Factors report “Direct to Consumer Genetic Testing Market By Test Type (Carrier Testing, Predictive testing, Ancestry & relationship testing, and Nutrigenomics testing), and By Technology (Targeted analysis, Single nucleotide, Polymorphism chips, and Whole genome sequencing): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026” states that the global Direct to Consumer Genetic Testing market in 2019 was approximately USD 714 million. The market is expected to grow at a CAGR of 19% and is anticipated to reach around USD 2400 million by 2026.
DTC testing is a means of marketing genetic testing to consumers without the direct involvement of a health professional. Increased prevalence in the DTC genetic testing industry is expected to drive the global development of genetic and rare diseases combined with major early detection and cancer prevention technologies and other genetic diseases in the coming years. Improved early diagnosis awareness among patients will lead to prompt therapy and reduced mortality rates. More important factors are technological innovations that improve efficiency, high sensitivity and precision in the process of direct genetic testing.
Browse the full “Direct to Consumer Genetic Testing Market By Test Type (Carrier Testing, Predictive testing, Ancestry & relationship testing, and Nutrigenomics testing), and By Technology (Targeted analysis, Single nucleotide, Polymorphism chips, and Whole genome sequencing): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026" https://www.fnfresearch.com/direct-to-consumer-genetic-testing-market-by-test-718
The growing demand for customized and improved medicinal products in the developing world will be a key factor in DTC genetic testing. The DTC tests allow customers to obtain useful ideas for genetic information with little or no intervention from healthcare professionals.
The new regulatory approval for several tests had played a major role in rapid market growth. Furthermore, the decline in the price of the genome sequencing process had made the genetic test comparatively inexpensive, leading to an increase in the number of tests ordered. However, the organizations offering these services are increasingly concerned with data protection and scientific validity, this might hamper the market growth of Direct to Consumer Genetic Testing over the forecast period.
Based on test type, nutrigenomics testing held the significant share of global direct to consumer genetic testing market in 2019; the segment was accounted for approximately USD 190million and is expected to witness robust growth throughout the forecast period. Increasing demand for customized meals and the desire to remain healthy among the population are some of the key factors fueling market growth.
By region, North America dominated the global direct to consumer genetic testing market in 2019 and is projected to continue bolstering throughout the forecast period with a CAGR of 15%. The growth of this region is attributed to the increased occurrence of genetic disease and to increase understanding of DTC-related among individuals.
Report Scope
Report Attribute |
Details |
Market Size in 2019 |
USD 714 Million |
Projected Market Size in 2026 |
USD 2400 Million |
CAGR Growth Rate |
19% CAGR |
Base Year |
2019 |
Forecast Years |
2020-2026 |
Key Market Players |
ancestry, EasyDNA, 23andMe, Color, Family Tree DNA, Pathway Genomics, Full Genomes, Genesis HealthCare, Helix, Karmagenes, MapMyGenome, Identigene, Living DNA, and Others |
Key Segment |
By Test, Technology, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Purchase Options |
Request customized purchase options to meet your research needs.Explore purchase options |
Some of the essential players operating in the Direct to Consumer Genetic Testing market, but not restricted to include
ancestry, EasyDNA, 23andMe, Color, Family Tree DNA, Pathway Genomics, Full Genomes, Genesis HealthCare, Helix, Karmagenes, MapMyGenome, Identigene, Living DNA, and others.
This report segments the Direct to Consumer Genetic Testing market as follows:
By Test Type Segmentation Analysis
- Carrier testing
- Predictive testing
- Ancestry & relationship testing
- Nutrigenomics testing
By Technology Segmentation Analysis
- Targeted analysis
- Single nucleotide
- Polymorphism chips
- Whole genome sequencing
By Regional Segmentation Analysis
- North America
- Europe
- Germany
- The UK
- France
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A - 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com
